NIH study finds number of steps taken daily may be more important for cancer risk than the intensity of activity.

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

NIH-funded study uses cutting-edge imaging techniques to reconstruct features underlying learning and memory in the mouse brain.

Preclinical study in rodents suggests that uric acid is ready for human clinical testing.

NIH-funded study supports use of adenotonsillectomy in this at-risk patient group.

Lassa fever is a viral hemorrhagic disease that can be fatal and that causes permanent hearing loss.

Criteria may help guide treatment of dermatitis.

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions.

The proposed approach is expected to save more than $65 million annually.

Study of CB1 receptor has implications for chronic pain treatment.

Nursing for at least six months may spur beneficial gut bacteria connected to better heart health years later.

High rate of oral immunotherapy side effects in NIH trial explains superiority of omalizumab.

NIH study reveals key players underlying disease onset and repair.

Dengue virus sickens as many as 400 million people each year, primarily in tropical and subtropical parts of the world.

NIH science lays groundwork for future studies in people.

Findings highlight the importance of infection prevention measures and personalized heart failure care.

NIH study identifies previously unknown adaptation.

NIH trial informs potential treatment strategy for kids who already tolerate half a peanut or more.